These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 17906642)

  • 1. RAR and RXR modulation in cancer and metabolic disease.
    Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR; Bourguet W; Altucci L; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoid receptors and therapeutic applications of RAR/RXR modulators.
    le Maire A; Alvarez S; Shankaranarayanan P; Lera AR; Bourguet W; Gronemeyer H
    Curr Top Med Chem; 2012; 12(6):505-27. PubMed ID: 22242853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
    Le Q; Dawson MI; Soprano DR; Soprano KJ
    Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
    Lefebvre P
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):153-64. PubMed ID: 12476796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
    Ahuja HS; Szanto A; Nagy L; Davies PJ
    J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective RXR modulators for the treatment of type II diabetes.
    Faul MM; Grese TA
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):974-85. PubMed ID: 12478728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of oncogenic transformation in acute promyelocytic leukemia: the hetero-union makes the force.
    Minucci S; Pelicci PG
    Cancer Cell; 2007 Jul; 12(1):1-3. PubMed ID: 17613430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diphenylamine-based retinoid antagonists: regulation of RAR and RXR function depending on the N-substituent.
    Ohta K; Kawachi E; Fukasawa H; Shudo K; Kagechika H
    Bioorg Med Chem; 2011 Apr; 19(8):2501-7. PubMed ID: 21459577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoids: potential in cancer prevention and therapy.
    Clarke N; Germain P; Altucci L; Gronemeyer H
    Expert Rev Mol Med; 2004 Nov; 6(25):1-23. PubMed ID: 15569396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective retinoic acid receptor ligands for rheumatoid arthritis.
    Beehler BC; Brinckerhoff CE; Ostrowski J
    Curr Opin Investig Drugs; 2004 Nov; 5(11):1153-7. PubMed ID: 15573865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic applications for ligands of retinoid receptors.
    Thacher SM; Vasudevan J; Chandraratna RA
    Curr Pharm Des; 2000 Jan; 6(1):25-58. PubMed ID: 10637371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of RXR function through ligand design.
    Pérez E; Bourguet W; Gronemeyer H; de Lera AR
    Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic retinoids: structure-activity relationships.
    Barnard JH; Collings JC; Whiting A; Przyborski SA; Marder TB
    Chemistry; 2009 Nov; 15(43):11430-42. PubMed ID: 19821467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors.
    García J; Khanwalkar H; Pereira R; Erb C; Voegel JJ; Collette P; Mauvais P; Bourguet W; Gronemeyer H; de Lera AR
    Chembiochem; 2009 May; 10(7):1252-9. PubMed ID: 19343742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the expression patterns of newly identified zebrafish retinoic acid and retinoid X receptors.
    Waxman JS; Yelon D
    Dev Dyn; 2007 Feb; 236(2):587-95. PubMed ID: 17195188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular interaction of retinoic acid receptors with coregulators PCAF and RIP140.
    Chen Y; Hu X; Wei LN
    Mol Cell Endocrinol; 2004 Oct; 226(1-2):43-50. PubMed ID: 15489004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
    Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
    Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13-cis-retinoic acid alters the cellular morphology of slice-cultured serotonergic neurons in the rat.
    Ishikawa J; Sutoh C; Ishikawa A; Kagechika H; Hirano H; Nakamura S
    Eur J Neurosci; 2008 May; 27(9):2363-72. PubMed ID: 18445226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity.
    Farooqui M; Franco PJ; Thompson J; Kagechika H; Chandraratna RA; Banaszak L; Wei LN
    Biochemistry; 2003 Feb; 42(4):971-9. PubMed ID: 12549917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.